ADMA Biologics-Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates

Adma Biologics (ADMA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of$ 0.13 per share. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 15.38%. A quarter ago, it was expected that this infectious disease drug developer would post earnings of$ 0.08 per share when it actually produced earnings of $0.13, delivering a surprise of 62.50%. Over the last ...